Mohamed A, Nagah Amer N, Osama N, Hafez W, Abdelrahman Ali A, Shaheen M
Noncoding RNA Res. 2025; 10():262-268.
PMID: 39844891
PMC: 11751402.
DOI: 10.1016/j.ncrna.2024.12.003.
Sun L, Ma Y, Geng C, Gao X, Li X, Ru Q
Mol Biol Rep. 2025; 52(1):126.
PMID: 39821530
DOI: 10.1007/s11033-025-10235-6.
Chen K, Zhu M, Hu Q, Huang H, Chen K, Shuai X
BMC Cancer. 2025; 25(1):83.
PMID: 39810131
PMC: 11731390.
DOI: 10.1186/s12885-024-13263-w.
Abdelhadi S, Rink J, Froelich M, Sandra-Petrescu F, El-Ahmar M, Oweira H
Langenbecks Arch Surg. 2025; 410(1):31.
PMID: 39786609
PMC: 11717872.
DOI: 10.1007/s00423-024-03565-9.
Lee J, Choi H, Kim J, Lee T, Yoon Y
Cancers (Basel). 2024; 16(23).
PMID: 39682279
PMC: 11640626.
DOI: 10.3390/cancers16234093.
TLN1: an oncogene associated with tumorigenesis and progression.
Li S, Chen A, Gui J, Zhou H, Zhu L, Mi Y
Discov Oncol. 2024; 15(1):716.
PMID: 39589610
PMC: 11599537.
DOI: 10.1007/s12672-024-01593-x.
Exploring the Impact of the β-Catenin Mutations in Hepatocellular Carcinoma: An In-Depth Review.
Idrissi Y, Rajabi M, Beumer J, Monga S, Saeed A
Cancer Control. 2024; 31:10732748241293680.
PMID: 39428608
PMC: 11528747.
DOI: 10.1177/10732748241293680.
Exploring Hepatocellular Carcinoma Pathogenesis: The Influence of Genetic Polymorphisms.
Mollazadeh S, Saeedi N, Al-Asady A, Ghorbani E, Khazaei M, Ryzhikov M
Curr Pharm Des. 2024; 31(6):432-442.
PMID: 39297458
DOI: 10.2174/0113816128327773240827062719.
Advancements in second-line treatment research for hepatocellular carcinoma.
Sun R, Wu C, Gou Y, Zhao Y, Huang P
Clin Transl Oncol. 2024; .
PMID: 39162977
DOI: 10.1007/s12094-024-03653-8.
The biological function of demethylase ALKBH1 and its role in human diseases.
Zhong J, Xu Z, Ding N, Wang Y, Chen W
Heliyon. 2024; 10(13):e33489.
PMID: 39040364
PMC: 11260981.
DOI: 10.1016/j.heliyon.2024.e33489.
A PNPLA3-Deficient iPSC-Derived Hepatocyte Screen Identifies Pathways to Potentially Reduce Steatosis in Metabolic Dysfunction-Associated Fatty Liver Disease.
Doueiry C, Kappler C, Martinez-Morant C, Duncan S
Int J Mol Sci. 2024; 25(13).
PMID: 39000384
PMC: 11242544.
DOI: 10.3390/ijms25137277.
Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon.
Galasso L, Cerrito L, Maccauro V, Termite F, Mignini I, Esposto G
Int J Mol Sci. 2024; 25(13).
PMID: 39000296
PMC: 11241080.
DOI: 10.3390/ijms25137191.
Effects of essential oil of Origanum onites and its major component carvacrol on the expression of toxicity pathway genes in HepG2 cells.
Tomsuk O, Kuete V, Sivas H, Kurkcuoglu M
BMC Complement Med Ther. 2024; 24(1):265.
PMID: 38992651
PMC: 11238398.
DOI: 10.1186/s12906-024-04571-6.
Proton Beam Therapy for Treating Patients with Hepatocellular Carcinoma with Major Portal Vein Tumor Invasion: A Single Center Retrospective Study.
Ishida T, Mizumoto M, Saito T, Okumura T, Miura K, Makishima H
Cancers (Basel). 2024; 16(11).
PMID: 38893169
PMC: 11171269.
DOI: 10.3390/cancers16112050.
Finding key genes (UBE2T, KIF4A, CDCA3, and CDCA5) co-expressed in hepatitis, cirrhosis and hepatocellular carcinoma based on multiple bioinformatics techniques.
Zhang Y, Yu W, Zhou S, Xiao J, Zhang X, Yang H
BMC Gastroenterol. 2024; 24(1):205.
PMID: 38890649
PMC: 11184838.
DOI: 10.1186/s12876-024-03288-7.
A Longitudinal Analysis of Mortality Related to Chronic Viral Hepatitis and Hepatocellular Carcinoma in the United States.
Ozturk N, Pham H, Mouhaffel R, Ibrahim R, Alsaqa M, Gurakar A
Viruses. 2024; 16(5).
PMID: 38793576
PMC: 11125803.
DOI: 10.3390/v16050694.
The janus face of serotonin: Regenerative promoter and chronic liver disease aggravator.
Mao B, Liu S, Zhu S, Wu F, Yuan W, Yan Y
Heliyon. 2024; 10(9):e30703.
PMID: 38756588
PMC: 11096747.
DOI: 10.1016/j.heliyon.2024.e30703.
Long Non-coding RNA PCED1B Antisense RNA 1 Promotes Cell Proliferation and Invasion in Hepatocellular Carcinoma by Regulating the MicroRNA-34a/CD44 Axis.
Bi J, Li Q, Guo Y, Liu L, Bao S, Xu P
Curr Med Sci. 2024; 44(3):503-511.
PMID: 38748366
DOI: 10.1007/s11596-023-2823-5.
ARHGAP17 Inhibits Hepatocellular Carcinoma Progression by Inactivation of Wnt/β-Catenin Signaling Pathway.
Fan S, Zhao H, Li C, Chen X, Sun M, Chen F
Biochem Genet. 2024; .
PMID: 38724713
DOI: 10.1007/s10528-024-10822-5.
A comprehensive review of phytoconstituents in liver cancer prevention and treatment: targeting insights into molecular signaling pathways.
Islam M, Rauf A, Alash S, Fakir M, Thufa G, Sowa M
Med Oncol. 2024; 41(6):134.
PMID: 38703282
DOI: 10.1007/s12032-024-02333-5.